De Fino, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 999
EU - Europa 955
AS - Asia 408
SA - Sud America 100
AF - Africa 15
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 2.484
Nazione #
US - Stati Uniti d'America 994
DE - Germania 357
SE - Svezia 223
CN - Cina 159
SG - Singapore 136
BR - Brasile 89
IT - Italia 72
FR - Francia 63
IE - Irlanda 51
UA - Ucraina 47
GB - Regno Unito 46
ID - Indonesia 35
FI - Finlandia 27
IN - India 27
RU - Federazione Russa 27
VN - Vietnam 12
CI - Costa d'Avorio 9
BE - Belgio 8
TR - Turchia 8
AT - Austria 7
IR - Iran 5
JP - Giappone 5
CL - Cile 4
IL - Israele 4
KR - Corea 4
NL - Olanda 4
PL - Polonia 4
SK - Slovacchia (Repubblica Slovacca) 4
A2 - ???statistics.table.value.countryCode.A2??? 3
HK - Hong Kong 3
AR - Argentina 2
AU - Australia 2
BG - Bulgaria 2
CA - Canada 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
MA - Marocco 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CH - Svizzera 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
ES - Italia 1
HU - Ungheria 1
IQ - Iraq 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
LI - Liechtenstein 1
MK - Macedonia 1
MX - Messico 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SV - El Salvador 1
TN - Tunisia 1
VE - Venezuela 1
Totale 2.484
Città #
Chandler 313
Singapore 86
Ashburn 63
Dublin 51
San Mateo 38
Wilmington 37
Jacksonville 35
Jakarta 35
Nürnberg 31
Beijing 30
New York 27
Nanjing 23
Boston 22
Los Angeles 20
Milan 20
Moscow 19
Princeton 19
Ann Arbor 18
Cattolica 14
Helsinki 14
Nanchang 14
Dearborn 13
Norwalk 13
Lawrence 12
Munich 12
Shanghai 11
Marseille 10
Abidjan 9
Frankfurt am Main 9
Hanoi 9
Bremen 8
Brussels 8
Chicago 8
Falls Church 8
Hebei 8
São Paulo 8
Woodbridge 8
Houston 7
Nuremberg 7
Rome 7
Mountain View 6
Pune 6
Düsseldorf 5
Fairfield 5
Izmir 5
Lviv 5
Portsmouth 5
Andover 4
Coquimbo 4
Fremont 4
Hefei 4
Kunming 4
Leawood 4
London 4
Mumbai 4
Redwood City 4
Seattle 4
Seoul 4
Tehran 4
Atlanta 3
Augusta 3
Brooklyn 3
Caxias do Sul 3
Changchun 3
Changsha 3
Chengdu 3
Edinburgh 3
Fairport 3
Falkenstein 3
Florence 3
Fuzhou 3
Ho Chi Minh City 3
Hong Kong 3
Jiaxing 3
Lancaster 3
Lauterbourg 3
Rio de Janeiro 3
The Dalles 3
Tianjin 3
Vienna 3
Amsterdam 2
Araucária 2
Auckland 2
Betim 2
Boardman 2
Bratislava 2
Buffalo 2
Chiavari 2
Chisinau 2
Chiswick 2
Clearwater 2
Curitiba 2
Fidenza 2
Goiânia 2
Guangzhou 2
Guayaquil 2
Gunzenhausen 2
Hangzhou 2
Hyderabad 2
Lodz 2
Totale 1.292
Nome #
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 209
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 154
Sleep Disordered Breathing in a cohort of patients with sporadic Inclusion Body Myositis. 125
Intravascular large B-cell lymphoma presenting as slowly progressive paraparesis with normal MRI features 108
Idiopathic inflammatory myopathies evaluated by near infrared spectroscopy 106
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 98
Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception 89
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 81
An atypical case of acute disseminated encephalomyelitis associated with cytomegalovirus infection 79
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis. 74
Defining the disease course of TNFα blockers-associated Multiple Sclerosis 72
BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression 71
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients 71
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 70
Magnetic resonance imaging pattern recognition in sporadic Inclusion-Body Myositis 69
Correction: BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression(PLoS ONE (2018) 1310 (e0206140) DOI: 10.1371/journal.pone.0206140) 69
A unique case of multiphasic ADEM or what else? 68
Focal muscle vibration, an effective rehabilitative approach in severe gait impairment due to multiple sclerosis 67
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 66
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients 63
Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study 60
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatment 59
The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre 58
The Prevalence of Multiple Sclerosis in the Metropolitan Area of Rome: A Capture-Recapture Analysis 57
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study 55
Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis 55
Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, Italy 54
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients 54
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 52
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report 48
Delayed hypersensitivity to dimethyl fumarate: Report of 1 case and literature review 44
Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approach 43
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis 37
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 29
Transient hair loss during treatment with dimethyl-fumarate for multiple sclerosis 28
Totale 2.542
Categoria #
all - tutte 12.825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.825


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202057 0 0 0 0 0 0 0 0 0 0 42 15
2020/2021117 10 11 1 9 8 7 8 4 13 8 31 7
2021/2022321 30 6 4 42 12 13 0 50 18 20 46 80
2022/2023730 97 111 65 121 41 87 29 58 70 10 27 14
2023/2024270 18 74 7 7 10 33 20 9 7 10 29 46
2024/2025473 19 23 51 31 32 34 12 19 84 45 123 0
Totale 2.542